Search results
Results from the WOW.Com Content Network
The approval was updated in September 2021, to include people aged twelve and older. [14] The Moderna Spikevax COVID-19 vaccine was authorized in Canada in September 2021, for people aged 12 and older. [22] [4] [182] The Moderna Spikevax COVID-19 vaccine was authorized in the US in January 2022, for people aged 18 and older. [1] [38] [41]
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...
The approval was granted under a breakthrough therapy designation and marks the second approved mRNA product from Moderna, the first being the famed COVID-19 vaccine. Earlier this month, the FDA ...
Moderna is asking federal regulators for full approval of its COVID-19 vaccine for people 18 and older, the company announced Tuesday.
On Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review of its Spikevax 2024-2025 formula, which targets the SARS-CoV-2 variant JN.1. The submission is ...
If approved, the Moderna vaccine could be available to certain segments of the population within two weeks. Pfizer and BioNTech also applied for emergency authorization for their jointly-developed ...
The COVID-19 vaccine produced by Moderna is set to be approved as early as this week by the U.S. Food and Drug Administration, a report said Tuesday. Moderna “has provided adequate information ...
The CDC approved Pfizer/BioNTech's (PFE/BNTX) bivalent COVID-19 booster for children ages 5-11 and Moderna's bivalent booster for ages 6-17 Wednesday, expanding access to protection against ...